How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level
| Autor: | Agnese Biagini, David Viola, Antonio Matrone, Eleonora Molinaro, Rossella Elisei, Laura Agate |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Diagnostic Imaging
Prognostic factor medicine.medical_specialty genetic structures Endocrinology Diabetes and Metabolism medicine.medical_treatment Serum thyroglobulin level behavioral disciplines and activities Gastroenterology Thyroglobulin Basal (phylogenetics) Endocrinology Internal medicine medicine Doubling time Humans In patient Thyroid Neoplasms Thyroid cancer business.industry medicine.disease Prognosis Neck ultrasound Neoplasm Recurrence Local business |
| Zdroj: | Endocrinology and metabolism clinics of North America. 43(2) |
| ISSN: | 1558-4410 |
| Popis: | Serum thyroglobulin (sTg) is the marker for monitoring persistence/recurrence of differentiated thyroid cancer, in patients without sTg antibodies. Patients with undetectable basal sTg or peak sTg |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|